McIlrath & Eck’s iShares iBonds Dec 2027 Term Corporate ETF IBDS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$62.8K Buy
2,590
+18
+0.7% +$437 ﹤0.01% 483
2025
Q4
$62.4K Buy
2,572
+37
+1% +$899 0.01% 312
2025
Q3
$61.7K Buy
2,535
+28
+1% +$679 0.01% 280
2025
Q2
$60.9K Buy
+2,507
New +$60.5K 0.01% 280

Other funds holding IBDS

McIlrath & Eck's IBDS Position: Q1 2026 in Review

McIlrath & Eck increased its iShares iBonds Dec 2027 Term Corporate ETF (IBDS) stake by 0.7% in Q1 2026, buying an estimated $437 and bringing the position to 2,590 shares worth $62.8K. The position accounts for ﹤0.01% of the portfolio, ranked #483.

McIlrath & Eck first reported a position in IBDS in Q2 2025 and has held it in 4 quarters since. 429 funds tracked by Wall St. Rank hold IBDS as of Q1 2026.

  • McIlrath & Eck held 2,590 shares of iShares iBonds Dec 2027 Term Corporate ETF worth $62.8K as of Q1 2026.
  • McIlrath & Eck bought 18 iShares iBonds Dec 2027 Term Corporate ETF shares in Q1 2026, an estimated $437.
  • iShares iBonds Dec 2027 Term Corporate ETF made up ﹤0.01% of McIlrath & Eck's portfolio in Q1 2026, its #483 holding.
  • McIlrath & Eck first reported a position in iShares iBonds Dec 2027 Term Corporate ETF in Q2 2025 and has held it in 4 quarters since.
  • 429 funds tracked by Wall St. Rank held iShares iBonds Dec 2027 Term Corporate ETF as of Q1 2026.

Based on McIlrath & Eck's 13F filing for Q1 2026, filed 19 May 2026.